Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fink

Showing results (231-240 of 890) with videos related to

Pageof 89
Sort By:
Archives of Toxicology|October 26, 2005
Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cellsJan Schrickx, Yuri Lektarau, J Fink-Gremmels
Physical Review Letters|January 13, 2019
Strong Spin Dependence of Correlation Effects in Ni Due to Stoner ExcitationsJ Sánchez-Barriga, R Ovsyannikov, J Fink
Journal of the Canadian Association of Radiologists|December 1, 1984
Nutrient foramina in the phalanges of the handsB Pastakia, I J Fink, K Morrish
Journal of Virology|November 1, 1994
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutantR Ramakrishnan, M Levine, D J Fink
Expert Opinion on Biological Therapy|April 14, 2006
Gene therapy for the treatment of sensory neuropathyMarina Mata, Munmun Chattopadhyay, David J Fink
Experimental Neurology|November 5, 2003
Therapeutic gene transfer with herpes-based vectors: studies in Parkinson's disease and motor nerve regenerationDavid J Fink, Joseph Glorioso, Marina Mata
Current Diabetes Reports|November 8, 2008
Gene therapy for the treatment of diabetic neuropathyMarina Mata, Munmun Chattopadhyay, David J Fink
Science (New York, N.Y.)|December 18, 1981
Tetramesityldisilene, a stable compound containing a silicon-silicon double bondR West, M J Fink, J Michl
International Anesthesiology Clinics|April 12, 2007
Viral vector-based gene transfer for treatment of chronic painShuanglin Hao, Marina Mata, David J Fink
Journal of Neurocytology|June 1, 1990
S100 is preferentially distributed in myelin-forming Schwann cellsM Mata, D Alessi, D J Fink
Pageof 89

Showing results (231-240 of 890) with videos related to

Sort By:
Pageof 89
Archives of Toxicology|October 26, 2005
Ochratoxin A secretion by ATP-dependent membrane transporters in Caco-2 cellsJan Schrickx, Yuri Lektarau, J Fink-Gremmels
Physical Review Letters|January 13, 2019
Strong Spin Dependence of Correlation Effects in Ni Due to Stoner ExcitationsJ Sánchez-Barriga, R Ovsyannikov, J Fink
Journal of the Canadian Association of Radiologists|December 1, 1984
Nutrient foramina in the phalanges of the handsB Pastakia, I J Fink, K Morrish
Journal of Virology|November 1, 1994
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutantR Ramakrishnan, M Levine, D J Fink
Expert Opinion on Biological Therapy|April 14, 2006
Gene therapy for the treatment of sensory neuropathyMarina Mata, Munmun Chattopadhyay, David J Fink
Experimental Neurology|November 5, 2003
Therapeutic gene transfer with herpes-based vectors: studies in Parkinson's disease and motor nerve regenerationDavid J Fink, Joseph Glorioso, Marina Mata
Current Diabetes Reports|November 8, 2008
Gene therapy for the treatment of diabetic neuropathyMarina Mata, Munmun Chattopadhyay, David J Fink
Science (New York, N.Y.)|December 18, 1981
Tetramesityldisilene, a stable compound containing a silicon-silicon double bondR West, M J Fink, J Michl
International Anesthesiology Clinics|April 12, 2007
Viral vector-based gene transfer for treatment of chronic painShuanglin Hao, Marina Mata, David J Fink
Journal of Neurocytology|June 1, 1990
S100 is preferentially distributed in myelin-forming Schwann cellsM Mata, D Alessi, D J Fink
Pageof 89